Mitsubishi Gas Chemical Company, Inc.

4182.T
Specialty Chemicals
2026/02/17 Updated
Market Cap: $5.3B (¥813.4B)
Stock Price: $27.32 (¥4,177)
Exchange Rate: 1 USD = ¥152.91

Notice Regarding Revision of Earnings Guidance

Consolidated operating income for the fiscal year ending March 2026 is revised upward by 6.8% from the previous forecast to 47,000 million yen, and ordinary income is revised up by 10.0% to 55,000 million yen. Meanwhile, net income attributable to owners of parent is revised downward by 1,000 million yen to a loss of 18,000 million yen.

Importance:
Page Updated: February 10, 2026
IR Disclosure Date: February 10, 2026

Key Figures

  • Consolidated Net Sales: 730,000 million yen (Same level as previous forecast)
  • Consolidated Operating Income: 47,000 million yen (+6.8% compared to previous forecast)
  • Consolidated Ordinary Income: 55,000 million yen (+10.0% compared to previous forecast)

AI要約

Details of the Revision to Earnings Guidance

In the consolidated earnings forecast for the fiscal year ending March 2026, net sales remain unchanged at 730,000 million yen from the previous forecast. Operating income has been revised upward to 47,000 million yen (a 6.8% increase from the previous forecast), and ordinary income has been revised upward to 55,000 million yen (a 10.0% increase). Meanwhile, net income attributable to owners of parent is expected to fall short of the previous forecast at a loss of 18,000 million yen due to impairment losses on fixed assets and other factors. Non-consolidated earnings guidance has been revised with similar trends.

Reasons and Assumptions for the Revision

The main reasons for the revision are the ongoing slump in the methanol market, a revised weaker yen exchange rate forecast at the fiscal year-end, and strong sales of BT materials for semiconductor packages. The exchange rates for the remaining months are set 10 yen weaker than the previous forecast at 155 yen per US dollar and 180 yen per euro. Although special income from the sale of non-operating assets is expected in the fourth quarter, impairment losses and other factors recorded in the third quarter are pressuring net income.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.